New Analyst Healthcare Stock Coverage: ZIOP, KH, BMTI
Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage in the Healthcare sector for the week ending November 25th, 2011.
- Ziopharm Oncology (NASDAQ:ZIOP): Collins Stewart initiated coverage of this company with a rating of Buy and a price target of $9 on Nov 22nd. About the company: ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs. Get the most recent company news and stock data here >>
- China Kanghui (NYSE:KH): Oppenheimer initiated coverage of this company with a rating of Outperform and a price target of $20 on Nov 22nd. About the company: China Kanghui Holdings, Inc. manufactures orthopedic medical devices. The Company produces trauma supplies including nails, plates and screws, and cranial maxillofacial plate and screw systems; and spinal products including screws, meshes, interbody cages, and fixation systems. Get the most recent company news and stock data here >>
- Biomimetic Therapeutics (NASDAQ:BMTI): Collins Stewart initiated coverage of this company with a rating of Buy and a price target of $7 on Nov 22nd. The shares recently traded at $3.07, up $0.07, or 2.33% since the analyst’s rating. About the company: BioMimetic Therapeutics, Inc. develops and markets drug-device products for the repair of orthopedic injuries to bond, cartilage, ligaments, and tendons. The Company combines protein therapeutics with tissue scaffolds to stimulate tissue healing and regeneration. Get the most recent company news and stock data here >>
(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)
Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>